Triple-Drug cocktail shows promise for tough endometrial cancer
NCT ID NCT01797523
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tested whether a combination of three drugs—everolimus, letrozole, and metformin—can help control advanced or recurrent endometrial cancer. The 62 participants had cancer that came back or spread and had limited prior treatments. The goal was to see how many patients had their cancer shrink or stop growing, using scans every 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Lyndon B Johnson General Hospital
Houston, Texas, 77026, United States
-
MD Anderson Cooper Cancer Center
Voorhees Township, New Jersey, 08043, United States
-
Memorial City Medical Center
Houston, Texas, 77024, United States
-
Sacred Heart Health Systems
Pensacola, Florida, 32504, United States
-
The Woman's Hospital of Texas
Houston, Texas, 77054, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.